Cochrane Abstracts
Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Short Acting Beta2‐agonist Use in Chronic Asthma: Regular Versus as Needed Treatment." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2‐agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment_Edited__no_change_to_conclusions_. Accessed 04 October 2023.
Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2‐agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment_Edited__no_change_to_conclusions_. Accessed October 4, 2023.
Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2‐agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment_Edited__no_change_to_conclusions_
Inhaled Short Acting Beta2‐agonist Use in Chronic Asthma: Regular Versus as Needed Treatment [Internet]. In: Cochrane Abstracts. [cited 2023 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2‐agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment
ID - 434045
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2‐agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
